Compass Therapeutics (CMPX) Retained Earnings (2018 - 2026)
Compass Therapeutics (CMPX) reported Retained Earnings of -$159000.0 for Q1 2026, down 183.68% on a YoY basis from $190000.0 in Q1 2025, and down 156.79% sequentially from $280000.0 in Q4 2025.
Compass Therapeutics (CMPX) Retained Earnings (2018 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 9 years of Retained Earnings data on file, last reported at -$159000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 183.68% year-over-year to -$159000.0; the trailing twelve-month figure through Mar 2026 stood at -$159000.0 (down 183.68% YoY), and the FY2025 full-year result was $280000.0, up 33.33% from the prior year.
- Retained Earnings retreated to -$159000.0 in Q1 2026, from $280000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $280000.0 in Q4 2025 to a low of -$349.7 million in Q3 2024.
- A 5-year average of -$90.3 million and a median of -$302000.0 in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings tumbled 223252.74% in 2024 and soared 328.57% in 2025, its largest moves.
- Tracing CMPX's Retained Earnings over 5 years: stood at -$302000.0 in 2022, then plunged by 104306.62% to -$315.3 million in 2023, then soared by 100.07% to $210000.0 in 2024, then jumped by 33.33% to $280000.0 in 2025, then slumped by 156.79% to -$159000.0 in 2026.
- Business Quant data shows CMPX's Retained Earnings at -$159000.0 in Q1 2026, $280000.0 in Q4 2025, and $274000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - | -159,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -159,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 210,000.00 |
| Sep 30, 2024 | -349.65 Mn |
| Jun 30, 2024 | -91,000.00 |
| Mar 31, 2024 | -326.10 Mn |
| Dec 31, 2023 | -315.31 Mn |
| Sep 30, 2023 | -301.89 Mn |
| Jun 30, 2023 | -507,000.00 |
| Mar 31, 2023 | -146,000.00 |
| Dec 31, 2022 | -302,000.00 |
| Sep 30, 2022 | -641,000.00 |
| Jun 30, 2022 | -512,000.00 |
| Mar 31, 2022 | -240.75 Mn |
| Dec 31, 2021 | -233.59 Mn |
| Sep 30, 2021 | -220.61 Mn |
| Mar 31, 2021 | -158.83 Mn |